Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial

Michiel Rienstra, Anne H. Hobbelt, Marco Alings, Jan G. P. Tijssen, Marcelle D. Smit, Johan Brugemann, Bastiaan Geelhoed, Robert G. Tieleman, Hans L. Hillege, Raymond Tukkie, Dirk J. Van Veldhuisen, Harry J. G. M. Crijns, Isabelle C. Van Gelder*, RACE 3 Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2987-2996
Number of pages10
JournalEuropean Heart Journal
Volume39
Issue number32
DOIs
Publication statusPublished - 21 Aug 2018

Keywords

  • Atrial fibrillation
  • Rhythm control
  • Risk factor management
  • Underlying conditions
  • END-POINT REDUCTION
  • HEART-FAILURE
  • CARDIOVASCULAR-DISEASE
  • LOSARTAN INTERVENTION
  • CATHETER ABLATION
  • HYPERTENSION LIFE
  • EUROPEAN-SOCIETY
  • BLOOD-PRESSURE
  • PREVENTION
  • MANAGEMENT
  • GUIDELINES
  • RISK

Cite this